The U.S. Food and Drug Administration has issued an alert concerning reports of liver injury in patients taking Prezista. The FDA said Prezista (darunavir), an anti-retroviral drug used to treat for the human immunodeficiency virus HIV, is suspected of contributing to several hepatic events, including liver failure, destruction of liver tissue, cirrhosis, hepatitis and jaundice.
Read article at physorg.com
Comment: All anti-retroviral drugs are toxic.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment